혈장 유래 의약품 시장 : 제품별, 용도별, 유통 채널별, 지역별

Global Plasma Derived Medicine Market is estimated to be valued at USD 19.87 Bn in 2025 and is expected to reach USD 32.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Figure. Plasma Derived Medicine Market Share (%), By Region 2025

Plasma derived medicines are manufactured using human blood plasma as the raw material. These medicines are used for treating various rare diseases like immune deficiency disorders, bleeding disorders, neurological disorders and more. Growing prevalence of rare diseases across the globe and advancements in therapy options can boost demand for plasma derived therapies. Furthermore, rising investments by government and private sectors in developing innovative treatments based on plasma derivatives can drive the market growth. However, high costs associated with plasma derived medication and stringent regulatory frameworks can hamper the market growth. Increasing emphasis on evidence-based treatment and emerging markets in developing nations can offer opportunities for plasma derived medicine providers in the near future.

Market Dynamics:

Global plasma derived medicine market growth is driven by rising prevalence of rare immunological and bleeding disorders worldwide. Growing adoption of plasma therapies to treat conditions like immune thrombocytopenia, hypogammaglobulinemia and neurological disorders can drive the market growth. Increasing healthcare spending coupled with evolving regulatory guidelines supporting manufacture of plasma derivatives can also drive the market growth. Emergence of innovative fractionation techniques and development of specialized bioprocessing infrastructure by market players facilitates the production of plasma derived drugs. However, high costs involved in plasma collection and complex production processes can hamper the rapid commercialization of plasma derived therapy. Stringent regulations regarding safety and efficacy evaluation can pose challenges for market players. Growing demand in emerging Asian and Latin American countries due to limited availability of alternative treatments can offer novel opportunities for manufacturers in the near future.

Key features of the study:

This report provides in-depth analysis of the global plasma derived medicine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global plasma derived medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Takeda Pharmaceutical Company Ltd., CSL Ltd., Grifols S.A., Octapharma AG, and Kedrion S.p.A

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global plasma derived medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasma derived medicine market

Detailed Segmentation-

• Product Insights (Revenue, USD Bn, 2020 - 2032)
  • Immunoglobulin
  • Coagulation factors
  • Albumin
  • Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Pelvic Inflammatory Disease (PID)
  • Bleeding Disorders
  • Alpha-1 Antitrypsin Deficiency (AATD)
  • Hereditary Angioedema (HAE)
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Guillain-Barre Syndrome
  • Multifocal Motor Neuropathy
  • Liver Diseases
  • Primary Immune Thrombocytopenia
  • Infections
  • Other Orphan Diseases
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • CSL Behring
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • Octapharma AG
  • Kedrion Biopharma
  • LFB S.A.
  • ADMA Biologics, Inc.
  • Bio Products Laboratory Ltd.
  • China Biologic Products Holdings, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • HemaCare Corporation
  • Sanquin Blood Supply Foundation
  • Biotest AG
  • Emergent BioSolutions Inc.
  • Medac GmbH
  • Scripps Laboratories
  • BPL (Bio Products Laboratory)
  • Fresenius Kabi AG
  • Kamada Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Plasma Derived Medicine Market, By Product
  • Global Plasma Derived Medicine Market, By Application
  • Global Plasma Derived Medicine Market, By Distribution Channel
  • Global Plasma Derived Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Plasma Derived Medicine Market, By Product, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Immunoglobulin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Coagulation factors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Plasma Derived Medicine Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Pelvic Inflammatory Disease (PID)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bleeding Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Alpha-1 Antitrypsin Deficiency (AATD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hereditary Angioedema (HAE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Inflammatory Demyelinating Polyneuropathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Guillain-Barre Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multifocal Motor Neuropathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Liver Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Primary Immune Thrombocytopenia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Orphan Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Plasma Derived Medicine Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Plasma Derived Medicine Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country/Sub-region, 2020 - 2032, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• CSL Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Grifols, S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Octapharma AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kedrion Biopharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LFB S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ADMA Biologics, Inc.
• Bio Products Laboratory Ltd.
• China Biologic Products Holdings, Inc.
• Shanghai RAAS Blood Products Co., Ltd.
• HemaCare Corporation
• Sanquin Blood Supply Foundation
• Biotest AG
• Emergent BioSolutions Inc.
• Medac GmbH
• Scripps Laboratories
• BPL (Bio Products Laboratory)
• Fresenius Kabi AG
• Kamada Pharmaceuticals

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us